Scientists find cancer cell defense method

October 5, 2005

A Seoul, South Korea, research team says it's identified the defense mechanism used by cancer cells to fight therapeutic chemicals.

Team leader Kim Kun-hong of Yonsei University told the Korea Times the discovery that enzyme protein kinase CK2 makes cancer cells resistant to cancer-specific therapeutic chemicals, such as "Trail," is a step toward developing effective treatments for the disease.

Kim said the enzyme influences a protein called procaspase-2 to become phosphate, which keeps the cells from dying and makes them resistant to medication.

However, when Trail was injected in the cancer cells with certain chemical substances the cells became sensitive to Trail and entered the normal death-inducing process.

The researchers tested 31 types of cancer cells and found that by suppressing PKCK2, Trail successfully killed the cancer cells in all the 31 types, regardless of the developmental stage of the cancer cell, Kim told the Korea Times.

The research appears in the online edition of the journal of the European Molecular Biology Organization.

Copyright 2005 by United Press International

Explore further: Researchers disguise drugs as platelets to target cancer

Related Stories

Researchers disguise drugs as platelets to target cancer

September 29, 2015

Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient's own platelets, allowing the drugs to last longer in the body and attack both primary cancer tumors and ...

Recommended for you

Aging star's weight loss secret revealed

November 25, 2015

A team of astronomers using ESO's Very Large Telescope has captured the most detailed images ever of the hypergiant star VY Canis Majoris. These observations show how the unexpectedly large size of the particles of dust surrounding ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.